Entrada Therapeutics, Inc. · NASDAQ:TRDA
ANSBERT GADICKE reported a 9.90% stake in Entrada Therapeutics, Inc. (Schedule 13D/A)
Event Sep 8, 2026 · Filed Sep 10, 2026
ANSBERT GADICKE reported a 9.90% stake in Entrada Therapeutics, Inc., 3,885,115 shares, with active intent on Sep 8, 2026. Filed Sep 10, 2026 (Schedule 13D/A).
- Stake
- 9.90%
- Shares
- 3,885,115
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MPM BioVentures 2014, L.P. | 4.50% | 1,764,167 |
| MPM BioVentures 2014 (B), L.P. | 0.30% | 117,667 |
| MPM Asset Management Investors BV2014 LLC | 0.20% | 60,722 |
| MPM BioVentures 2014 GP LLC | 4.80% | 1,881,834 |
| MPM BioVentures 2014 LLC | 5.00% | 1,942,556 |
| MPM BIOVENTURES 2018, L.P. | 4.70% | 1,810,592 |
| MPM BIOVENTURES 2018 (B), L.P. | 0.20% | 96,232 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | 0.10% | 35,735 |
| MPM BioVentures 2018 GP LLC | 4.90% | 1,906,824 |
| MPM BioVentures 2018 LLC | 5.00% | 1,942,559 |
| ANSBERT GADICKE | 9.90% | 3,885,115 |
| LUKE EVNIN | 9.90% | 3,885,115 |
| Todd Foley | 9.90% | 3,885,115 |
Source
Related
- Entrada Therapeutics, Inc.
- Ansbert Gadicke
- Entrada Therapeutics, Inc. shareholders
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026
- Form 4 · Dowden Nathan J · Sep 3, 2026